A Potential Diagnostic Approach for Foetal Long-QT Syndrome, Developed and Validated in Children

Arja Suzanne Vink1,2, Irene M Kuipers3, Rianne H A C M De Bruin-Bon4

  • 1Heart Centre, Department of Cardiology, Academic Medical Centre, University of Amsterdam, PO Box 22660, 1100 DD, Amsterdam, The Netherlands. a.s.vink@amc.uva.nl.

Insights

Mechanical abnormalities in Long-QT Syndrome (LQTS) can be detected by measuring myocardial contraction duration. This method shows promise for diagnosing LQTS in fetuses, where ECG is unavailable.

Area of Science:

  • Cardiology
  • Fetal Medicine
  • Biomedical Engineering

Background:

  • Long-QT Syndrome (LQTS) is associated with mechanical cardiac abnormalities.
  • Current diagnostic methods for fetal LQTS, such as DNA analysis, are invasive.
  • Non-invasive markers for fetal LQTS diagnosis are needed.

Purpose of the Study:

  • To develop and validate myocardial contraction duration as a marker for LQTS in children.
  • To assess the feasibility of using myocardial contraction duration for prenatal LQTS diagnosis.

Main Methods:

  • Myocardial contraction duration was measured using color Tissue Doppler Imaging (cTDI).
  • The study included 41 LQTS children and matched controls, and a pilot study of 7 LQTS fetuses and 8 controls.
  • Measurements in children were validated against simultaneously recorded ECGs.

Main Results:

  • LQTS children exhibited a significantly longer myocardial contraction duration than controls, independent of heart rate.
  • The measurement demonstrated high inter- and intra-observer validity and correlated well with the QT-interval.
  • Feasibility was confirmed in fetuses, with LQTS fetuses showing a trend towards longer contraction duration.

Conclusions:

  • Prolonged myocardial contraction duration is a potential non-invasive marker for diagnosing LQTS in children.
  • This measurement is feasible in fetuses and may serve as a future prenatal diagnostic tool for LQTS.
  • Further research is warranted to establish myocardial contraction duration as a definitive diagnostic approach for fetal LQTS.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
287
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
858
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Data Validation01:15

Data Validation

Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.1K
Data Validation01:03

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.9K